NCT00919282
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
- Locations
-
- Universitätsmedizin Berlin Berlin, State of Berlin, Germany
Clinical trial condition
Metastatic Pancreatic Cancer
Explore clinical trials studying Metastatic Pancreatic Cancer. Study availability and eligibility vary by location and protocol.
131 public trials
28 recruiting studies
Metastatic Pancreatic Cancer trial results
Completed
Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer
NCT00222469
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
- Locations
-
- University of Oklahoma Oklahoma City, Oklahoma, United States
- MD Anderson Cancer Center Houston, Texas, United States
NCT00245362
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
- Locations
-
- Johns Hopkins University School of Medicine Baltimore, Maryland, United States
- US Oncology Dallas, Texas, United States
Active, Not Recruiting
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
NCT03816163
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
- Locations
-
- St. Joseph Heritage Medical Group Fullerton, California, United States
- TOI Clinical research Whittier, California, United States
- Midstate Medical Center Meriden, Connecticut, United States
- Lynn Cancer Institute Boca Raton, Florida, United States
Active, Not Recruiting
Early Treatment ctDNA Dynamics to Predict Response to Chemotherapy
NCT07122466
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
- Locations
-
- Zuckerberg Cancer Center New Hyde Park, New York, United States
Active, Not Recruiting
A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors
NCT05143970
- Conditions
- Adnexal Diseases, Advanced Solid Tumor, Breast Diseases, +48 more
- Locations
-
- Institut Paoli Calmettes Marseille, France
Active, Not Recruiting
Proglumide and Chemotherapy for Metastatic Pancreatic Cancer
NCT05827055
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
- Locations
-
- Lombardi Comprehensive Cancer Center, Georgetown University Washington D.C., District of Columbia, United States
Active, Not Recruiting
Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.
NCT04753879
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
Active, Not Recruiting
Saltikva for Metastatic Pancreatic Cancer
NCT04589234
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
- Locations
-
- Segal Cancer Centre/ Mortimer B. Davis-Jewish General Hosptial Montreal, Quebec, Canada
Active, Not Recruiting
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
NCT03682289
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +43 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California, San Francisco San Francisco, California, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States